Tempest Therapeutics (NASDAQ:TPST – Get Free Report) is expected to be releasing its earnings data before the market opens on Tuesday, March 18th. Analysts expect Tempest Therapeutics to post earnings of ($0.24) per share for the quarter.
Tempest Therapeutics Price Performance
NASDAQ:TPST opened at $0.84 on Monday. Tempest Therapeutics has a 1-year low of $0.70 and a 1-year high of $6.00. The business has a 50 day moving average of $0.89 and a 200 day moving average of $1.01. The company has a market capitalization of $36.64 million, a price-to-earnings ratio of -0.55 and a beta of -1.83.
Tempest Therapeutics Company Profile
Featured Articles
- Five stocks we like better than Tempest Therapeutics
- Why is the Ex-Dividend Date Significant to Investors?
- How to Build the Ultimate Everything ETF Portfolio
- What is a Special Dividend?
- Dutch Bros or Starbucks: Which Coffee Stock Has More Growth?
- What Makes a Stock a Good Dividend Stock?
- 3 Stocks With High ROE and Market-Beating Growth Potential
Receive News & Ratings for Tempest Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tempest Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.